Home/Filings/4/0000908662-16-000458
4//SEC Filing

ENANTA PHARMACEUTICALS INC 4

Accession 0000908662-16-000458

$ENTACIK 0001177648operating

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:08 PM ET

Size

5.3 KB

Accession

0000908662-16-000458

Insider Transaction Report

Form 4
Period: 2016-02-11
Vance Terry
Director
Transactions
  • Award

    Stock Option (right to buy)

    2016-02-11+6,0006,000 total
    Exercise: $25.58Exp: 2026-02-11Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 11, 2016), with the final monthly installment vesting at the 2017 annual meeting of stockholders.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeoperating

Related Parties

1
  • filerCIK 0001177648

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:08 PM ET
Size
5.3 KB